Annual Cash & Cash Equivalents
$32.31 M
-$20.94 M-39.33%
December 31, 2021
Summary
- As of February 10, 2025, ETTX annual cash & cash equivalents is $32.31 million, with the most recent change of -$20.94 million (-39.33%) on December 31, 2021.
- During the last 3 years, ETTX annual cash & cash equivalents has fallen by -$17.05 million (-34.55%).
Performance
ETTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$33.55 M
+$1.24 M+3.84%
March 31, 2022
Summary
- As of February 10, 2025, ETTX quarterly cash and cash equivalents is $33.55 million, with the most recent change of +$1.24 million (+3.84%) on March 31, 2022.
- Over the past year, ETTX quarterly cash and cash equivalents has dropped by -$11.39 million (-25.35%).
Performance
ETTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ETTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.3% | -25.4% |
| 3 y3 years | -34.5% | +147.8% |
| 5 y5 years | -41.4% | - |
ETTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -3.7% |
| 5 y | 5-year | -39.3% | -50.4% | -45.2% | -52.2% |
| alltime | all time | -41.4% | -50.4% | -64.3% | -84.5% |
Entasis Therapeutics Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $33.55 M(+3.8%) |
| Dec 2021 | $32.31 M(-39.3%) | $32.31 M(-26.8%) |
| Sep 2021 | - | $44.12 M(-21.8%) |
| Jun 2021 | - | $56.41 M(+25.5%) |
| Mar 2021 | - | $44.94 M(-15.6%) |
| Dec 2020 | $53.25 M(+232.1%) | $53.25 M(-13.0%) |
| Sep 2020 | - | $61.19 M(+20.5%) |
| Jun 2020 | - | $50.77 M(+191.0%) |
| Mar 2020 | - | $17.45 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $16.03 M(-67.5%) | $16.03 M(+4.8%) |
| Sep 2019 | - | $15.30 M(+194.4%) |
| Jun 2019 | - | $5.20 M(-61.6%) |
| Mar 2019 | - | $13.54 M(-72.6%) |
| Dec 2018 | $49.36 M(-10.4%) | $49.36 M(-47.5%) |
| Sep 2018 | - | $94.02 M(+179.5%) |
| Jun 2018 | - | $33.64 M(-38.9%) |
| Dec 2017 | $55.10 M(+109.9%) | $55.10 M |
| Dec 2016 | $26.26 M | - |
FAQ
- What is Entasis Therapeutics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings annual cash & cash equivalents year-on-year change?
- What is Entasis Therapeutics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
What is Entasis Therapeutics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ETTX is $32.31 M
What is the all time high annual cash & cash equivalents for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high annual cash & cash equivalents is $55.10 M
What is Entasis Therapeutics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ETTX annual cash & cash equivalents has changed by -$20.94 M (-39.33%)
What is Entasis Therapeutics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ETTX is $33.55 M
What is the all time high quarterly cash and cash equivalents for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high quarterly cash and cash equivalents is $94.02 M
What is Entasis Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, ETTX quarterly cash and cash equivalents has changed by -$11.39 M (-25.35%)